KLK7 and carcinoma: In a study of 44 ovarian tumors (12 low malignant and 32 carcinomas), Tanimoto et al. [78] showed that levels of KLK7 mRNA were elevated in 66.7% of low malignant potential tumor cells and in 78.1% of malignant cells, suggesting that the overexpression of KLK7 in ovarian tumors contributes to tumor cell growth and metastasis.